Development and validation of an LC–MS/MS method for the determination of adapalene in pharmaceutical forms for skin application

Main Article Content

Vladimir Dobričić
Nataša Bubić Pajić
Bojan Marković
Sote Vladimirov
Snežana Savić
Gordana Vuleta

Abstract

The development and validation of a liquid chromatography– tandem mass spectrometry (LC–MS/MS) method for the determination of adapalene in pharmaceutical forms for skin application were presented in this study. The MS/MS analysis of adapalene was performed by use of three mobile phases, consisted of acetonitrile and a) 0.1 % formic acid, b) 0.1 % trifluoroacetic acid and c) 20 mM ammonium acetate. The strongest signals of parent ion and dominant product ion were obtained in negative mode by use of the mobile phase c). The validation of this method was performed according to the ICH gu­idelines. Small variations of selected chromatographic parameters (concen­tra­tion of ammonium acetate, mobile phase composition, column temperature and flow rate) did not affect sig­nificantly the qualitative and quantitative sys­tem responses, which proved the methods robustness. The method is specific for the determination of adapalene. The linearity was proved in the concentra­tion range of 6.7–700.0 ng mL-1 (r = 0.9990), with limits of detection and quantific­ation of 2.0 and 6.7 ng mL-1, respectively. The accuracy was con­firmed by cal­culated recoveries (98.4–101.5 %). The precision was tested at three levels: injection repeatability, analysis repeatability and intermediate pre­cision. The calcu­lated relative standard deviations were less than 1, 2 and 3 %, respect­ively.

Downloads

Download data is not yet available.

Metrics

Metrics Loading ...

Article Details

How to Cite
[1]
V. Dobričić, N. Bubić Pajić, B. Marković, S. Vladimirov, S. Savić, and G. Vuleta, “Development and validation of an LC–MS/MS method for the determination of adapalene in pharmaceutical forms for skin application”, J. Serb. Chem. Soc., vol. 81, no. 10, pp. 1171–1181, Oct. 2016.
Section
Analytical Chemistry

References

H. Gollnick, W. Cunliffe, D. Berson, B. Dreno, A. Finlay, J. J. Leyden, A. R. Shalita, D. J. Thiboutot, J. Am. Acad. Dermatol. 49 (2003) S1

Product information Differin® adapalene 0.1 % topical gel, http://www.galde¬r-ma.com.au/

/LinkClick.aspx?fileticket=KO3vZ2oZ6yM%3D&portalid= 4 (January 10, 2016)

A. L. Zaenglein, Semin. Cutan. Med. Surg. 27 (2008) 177

L. Trichard, M. B. Delgado-Cherra, R. H. Guy, E. Fattal, A. Bochot, Pharm. Res. 25 (2008) 435

G. Bhatia, Y. Zhou, A. K. Banga, J. Pharm. Sci. 8 (2013) 2622

A. Lauterbach, C. Mueller-Goymann, Int. J. Pharm. 466 (2014) 122

European Pharmacopoeia 7.0, Council of Europe, Strasbourg, 2010, pp. 1324–1326

M. Mudasir, N. Tabassum, J. Ali, N. A. Khan, R. Jan, Res. J. Pharm. Biol. Chem. Sci. 2 (2011) 231

L. A. Martins, L. Z. Meneghini, C. A. Junqueira, D. C. Ceni, A. M. Bergold, J. Chro-matogr. Sci. 49 (2011) 796

R. M. Chandira, Pradeep, A. Pasupathi, D. Bhowmik, Chiranjib, B. Jayakar, K. K. Tripathi, K. P. Sampath Kumar, J. Chem. Pharm. Res. 2 (2010) 401

S. S. Pujeri, A. M. A. Khader, J. Seetharamappa, J. Anal. Chem. 67 (2012) 585

J. G. Barrios, G. DAvila Farias, I. Roggia, S. Cadore Peixoto, F. R. Pons, M. Bruschi, R. Platcheck Raffin, M. Palma Alves, Quim. Nova 34 (2011) 1464

S. S. Deo, F. Inam, N. P. Karmarkar, Chem. Sci. Trans. 2 (2013) 251

R. Rühl, H. Nau, Chromatographia 45 (1997) 269

E. Brenna, S. Frigoli, G. Fronza, C. Fuganti, F. Sala, J. Pharmaceut. Biomed. 43 (2007) 1161

A. Q. Laghari, A. Nelofar, A. Kandhro, L. A. Yasmin, Int. J. Res. Pharm. Biomed. Sci. 2 (2013) 5

Y. S. Nam, I. K. Kwon, Y. Lee, K. B. Lee, Forensic Sci. Int. 220 (2012) e23

J. Fiori, V. Andrisano, J. Pharm. Biomed. Sci. 91 (2014) 185

J. Golubović, B. Otašević, A. Protić, A. Stanković, M. Zečević, Rapid Commun. Mass Spectrom. 29 (2015) 2319

International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use, ICH Harmonised Tripartite Guideline (2005), Validation of Analytical Procedures: Text and Methodology Q2(R1), Complementary Guideline on Methodology, dated 06 November 1996, incorporated in November 2005, London, 2005

J. Crowther, in Handbook of modern pharmaceutical analysis, S. Ahuja, S. Scypinsky, Eds., Academic Press, San Diego, CA, 2001, p. 415.

Most read articles by the same author(s)